Loncar Cancer Immunotherapy ETF Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (19)

Latest Posts

About This Stock More About This Stock
Moderna - A Step Closer To Coronavirus Vaccine: ETFs To Gain
Article By: Zacks Investment Research
Sunday, June 14, 2020 3:44 PM EDT
The first company to start human clinical trials of its coronavirus vaccine candidate in the United States — Moderna — has informed that it is on schedule to initiate the final-stage clinical trial by July.
In this article: AZN, JNJ, BBH, MRNA, CNCR, IDNA Also: IBB, XBI
3 ETFs For More Moderna Bets
Article By: Benzinga
Tuesday, May 19, 2020 10:50 AM EDT
Shares of biotechnology company Moderna Inc jumped 20% Monday on news that its mRNA-1273 coronavirus vaccine candidate is making positive progress.
In this article: CNCR, BTEC, IDNA, MRNA
EC Top Precision Medicine Stocks
Article By: Fred Fuld
Sunday, January 19, 2020 1:13 PM EDT
In precision medicine, the focus is on identifying which approaches will be effective for which patients based on genetic, environmental, and lifestyle factors. For investors, there are a few stocks that participate in this industry.
In this article: BMRN, ILMN, VRTX, VRML, CNCR, IQV
The Landscape Of Biotech ETFs
Article By: Nancy Zhang
Tuesday, January 8, 2019 2:17 AM EDT
The challenge is to create a quality biotech index with a rule-based system, so the picking and re-balancing are handy and quick.
In this article: IBB, PBE, BBC, CNCR
3 Sector ETFs That Gained Double-Digits In Q1
Article By: Sweta Killa
Friday, March 30, 2018 8:46 PM EDT
Although most sectors are deep in the red, there are still a few that have survived the market turbulence in the first quarter, sector ETFs that have gained in double-digits and could be better plays in the months ahead should the trends prevail.
In this article: CNCR, XWEB, IBUY Also: FB


Latest Tweets for $CNCR

No tweets yet!